Evidence map›Paper›PMID 30173346›Full record

ArticleTransgenic research2018

Variability of CP4 EPSPS expression in genetically engineered soybean (Glycine max L. Merrill).

Parimala Chinnadurai, Duška Stojšin, Kang Liu, Gregory E Frierdich, Kevin C Glenn, Tao Geng, Adam Schapaugh, Keguo Huang, Andrew E Deffenbaugh, Zi L Liu and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Transgenic research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Parimala ChinnaduraiBayer Crop Sciences, 700 Chesterfield Parkway West, St. Louis, MO, 63017, USA.
Duška StojšinBayer Crop Sciences, 700 Chesterfield Parkway West, St. Louis, MO, 63017, USA.
Kang LiuBayer Crop Sciences, 700 Chesterfield Parkway West, St. Louis, MO, 63017, USA.
Gregory E FrierdichBayer Crop Sciences, 700 Chesterfield Parkway West, St. Louis, MO, 63017, USA.
Kevin C GlennBayer Crop Sciences, 700 Chesterfield Parkway West, St. Louis, MO, 63017, USA.
Tao GengBayer Crop Sciences, 700 Chesterfield Parkway West, St. Louis, MO, 63017, USA.
Adam SchapaughBayer Crop Sciences, 700 Chesterfield Parkway West, St. Louis, MO, 63017, USA.
Keguo HuangBayer Crop Sciences, 700 Chesterfield Parkway West, St. Louis, MO, 63017, USA.
Andrew E DeffenbaughBayer Crop Sciences, 700 Chesterfield Parkway West, St. Louis, MO, 63017, USA. andrew.deffenbaugh@bayer.com.ORCID 0000-0002-8364-6186
Zi L LiuBayer Crop Sciences, 700 Chesterfield Parkway West, St. Louis, MO, 63017, USA.
Luis A BurzioBayer Crop Sciences, 700 Chesterfield Parkway West, St. Louis, MO, 63017, USA.
Bayer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression of the CP4 EPSPS protein in genetically engineered (GE) soybean confers tolerance to the Roundup

Indexed as

Drug Tolerance3-Phosphoshikimate 1-CarboxyvinyltransferaseAgrobacteriumGlycineGlycine maxGlyphosateHerbicidesPlants, Genetically Modified3-Phosphoshikimate 1-CarboxyvinyltransferaseGlycineGlyphosateHerbicidesCP4 EPSPSExpression variationGE cropsGlyphosate-toleranceMOESoybean

Identifiers

PMID30173346
PMCPMC6267263
OpenAlexW2889552218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.